These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22999567)

  • 1. Clinical utility of vagus nerve stimulation for progressive myoclonic epilepsy.
    Fujimoto A; Yamazoe T; Yokota T; Enoki H; Sasaki Y; Nishimura M; Yamamoto T
    Seizure; 2012 Dec; 21(10):810-2. PubMed ID: 22999567
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic high-frequency deep brain stimulation of the STN/SNr for progressive myoclonic epilepsy.
    Vesper J; Steinhoff B; Rona S; Wille C; Bilic S; Nikkhah G; Ostertag C
    Epilepsia; 2007 Oct; 48(10):1984-9. PubMed ID: 17561948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies.
    Cersósimo RO; Bartuluchi M; Fortini S; Soraru A; Pomata H; Caraballo RH
    Epileptic Disord; 2011 Dec; 13(4):382-8. PubMed ID: 22258042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myoclonic epilepsies.
    Conry JA
    J Child Neurol; 2002 Jan; 17 Suppl 1():S80-4. PubMed ID: 11918469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?
    Spatola M; Jeannet PY; Pollo C; Wider C; Labrum R; Rossetti AO
    Eur Neurol; 2013; 69(2):119-21. PubMed ID: 23207687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.
    Shahwan A; Farrell M; Delanty N
    Lancet Neurol; 2005 Apr; 4(4):239-48. PubMed ID: 15778103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead revision surgery for vagus nerve stimulation in epilepsy: outcomes and efficacy.
    Waseem H; Raffa SJ; Benbadis SR; Vale FL
    Epilepsy Behav; 2014 Feb; 31():110-3. PubMed ID: 24389021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy.
    De Herdt V; Bogaert S; Bracke KR; Raedt R; De Vos M; Vonck K; Boon P
    J Neuroimmunol; 2009 Sep; 214(1-2):104-8. PubMed ID: 19608283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
    Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?
    Badawy RA; Macdonell RA; Jackson GD; Berkovic SF
    Epilepsia; 2010 Oct; 51(10):2084-8. PubMed ID: 20384725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.
    Stefan H; Kreiselmeyer G; Kerling F; Kurzbuch K; Rauch C; Heers M; Kasper BS; Hammen T; Rzonsa M; Pauli E; Ellrich J; Graf W; Hopfengärtner R
    Epilepsia; 2012 Jul; 53(7):e115-8. PubMed ID: 22554199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagus nerve stimulation in drug-resistant epilepsies. Analysis of potential prognostic factors in a cohort of patients with long-term follow-up.
    Colicchio G; Montano N; Fuggetta F; Papacci F; Signorelli F; Meglio M
    Acta Neurochir (Wien); 2012 Dec; 154(12):2237-40. PubMed ID: 23086106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between vagus nerve stimulation efficacy and partial onset epilepsies.
    Burakgazi AZ; Burakgazi-Dalkilic E; Caputy AJ; Potolicchio SJ
    J Clin Neurophysiol; 2011 Aug; 28(4):380-3. PubMed ID: 21811127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagus nerve stimulation in refractory epilepsy: new indications and outcome assessment.
    Marras CE; Chiesa V; De Benedictis A; Franzini A; Rizzi M; Villani F; Ragona F; Tassi L; Vignoli A; Freri E; Specchio N; Broggi G; Casazza M; Canevini MP
    Epilepsy Behav; 2013 Sep; 28(3):374-8. PubMed ID: 23835092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.
    de Siqueira LF
    J Neurol; 2010 Oct; 257(10):1612-9. PubMed ID: 20593193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A pedigree with dentatorubralpallidolyysian atrophy].
    Lu X; Xie F; Cen Z; Wu H; Zheng X; Chen Y; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):934-935. PubMed ID: 29188634
    [No Abstract]   [Full Text] [Related]  

  • 18. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry.
    Levy ML; Levy KM; Hoff D; Amar AP; Park MS; Conklin JM; Baird L; Apuzzo ML
    J Neurosurg Pediatr; 2010 Jun; 5(6):595-602. PubMed ID: 20515333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mania following vagus nerve stimulation: a case report and review of the literature.
    Gerson R; Murray E; Price B; Frankel M; Douglass LM; Cunningham M
    Epilepsy Behav; 2011 Jan; 20(1):138-40. PubMed ID: 21167787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action myoclonus-renal failure syndrome: the definitive clinico-pathological description.
    Brown P
    Brain; 2004 Oct; 127(Pt 10):2151-2. PubMed ID: 15385427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.